These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Heparin and low molecular weight heparin in thrombosis and beyond.
    Author: Mousa SA.
    Journal: Curr Opin Investig Drugs; 2002 Aug; 3(8):1181-6. PubMed ID: 12211411.
    Abstract:
    Despite efforts in finding and developing new anticoagulants, unfractionated heparin and low molecular weight heparin (LMWH) will continue to play a pivotal role in the management of thrombotic disorders. While bleeding and heparin-induced thrombocytopenia represent major side effects of this drug, it has remained the anticoagulant of choicefor the prophylaxis and treatment of arterial and venous thrombotic disorders, surgical anticoagulation and interventional usage. Understanding the heparin structure led to the development of LMWHs, synthetic heparinomimetics, antithrombin and anti-Factor Xa agents.
    [Abstract] [Full Text] [Related] [New Search]